 | |
| Established | 2011 |
|---|---|
| Research type | Basic (non-clinical), Clinical research and translational research |
Field of research | Genomics, Bioinformatics, DNA sequencing, Whole genome sequencing |
| Director | Tom Maniatis, PhD,[1] Evnin Family Scientific Director & CEO |
| Location | New York City, New York, United States |
| Affiliations |
|
| Harold E. Varmus, MD | |
| Website | New York Genome Center |
The New York Genome Center (NYGC) is an independent 501(c)(3) nonprofit academic research institution in New York, New York.[3] It serves as a multi-institutional collaborative hub focused on the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC's areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 genomics research.
- ^ "Tom Maniatis". People in the News. genomeweb. 18 August 2017. Retrieved 20 October 2017.
- ^ "About Us". New York Genome Center. Our Members.[self-published source]
- ^ Duignan, Christopher (13 August 2015). "Form 990: Return of Organization Exempt From Income Tax" (PDF). GuideStar. p. 1. Retrieved 22 November 2016.